Results 61 to 70 of about 113,982,624 (231)

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

Phytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko, Victoriya Georgiyants, Liudas Ivanauskas, Olha Mykhailenko   +3 more
wiley   +1 more source

Immunoglobulin A nephropathy and Henoch–Schönlein purpura

, 2010
Immunoglobulin A nephropathy (IgAN) is the commonest pattern of glomerulonephritis identified in areas of the world where renal biopsy is widely practised.
John Feehally, Jonathan Barratt
core   +1 more source

Effect of dapagliflozin on proteinuria and the slope of the estimated glomerular filtration rate in patients with immunoglobulin A nephropathy: A multicenter prospective study

Journal of International Medical Research
Objective The sodium–glucose cotransporter-2 inhibitor dapagliflozin reduces proteinuria and slows the decline in estimated glomerular filtration rate in patients with chronic kidney disease.
Takeo Koshida, Hitoshi Suzuki, Maki Murkoashi, Hisatsugu Takahara, Yusuke Suzuki, Tomohito Gohda   +5 more
doaj   +1 more source

Prevalence of IgA Nephropathy: A 10 Years’ Experience from Jinnah Postgraduate Medical Centre, Karachi, Pakistan

Pakistan Journal of Medicine and Dentistry
Background: Immunoglobulin A (IgA) is considered the most frequently dealt primary glomerulonephritis, worldwide. The Berger’s disease or IgA nephropathy is a mesangial proliferative glomerulonephritis characterized by deposition of immunoglobulin A ...
Muhammad Ali, Shafique Ahmed, Ayesha Ejaz, Ghazala Usman, Abdul MananJunejo, Hina Iram, Moiz Ahmed   +6 more
doaj   +1 more source

Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease

VIEW, EarlyView.
This study investigated gut microbiota dysbiosis and its association with Long COVID susceptibility in 224 hemodialysis patients. We found that 35.3% of patients developed Long COVID, characterized by neurological symptoms and elevated inflammatory markers, accompanied by significant gut microbiota alterations including enriched proinflammatory taxa ...
Meiling Jin, Lijie Ma, Yuqing Yuan, Kaiyi Zhu, Zhaohui Tong, Qianmei Sun   +5 more
wiley   +1 more source

Comparison of two protocols for steroid pulse therapy in patients with IgA nephropathy: a retrospective observational study

BMC Nephrology, 2022
Background Steroid pulse (SP) therapy is one of the immunosuppressive therapies for immunoglobulin A nephropathy (IgAN). Although there are various protocols of SP therapy in IgAN, the intermittent SP (ISP) and consecutive SP (CSP) protocols are ...
Satoshi Yamatani, Keiji Kono, Hideki Fujii, Ken Hirabayashi, Mao Shimizu, Kentaro Watanabe, Shunsuke Goto, Shinichi Nishi   +7 more
doaj   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source

Hereditary spherocytosis with immunoglobulin A nephropathy

, 2010
Hereditary spherocytosis is a familial hemolytic anemia. Immunoglobulin A (IgA) nephropathy associated with hereditary spherocytosis has not been reported in children.

core   +1 more source

Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis [PDF]

, 2008
Background: Diabetic nephropathy (DN) is a complex and chronic metabolic disease that evolves into a progressive fibrosing renal disorder. Effective transcriptomic profiling of slowly evolving disease processes such as DN can be problematic.
Seifert, Martin, Hermann-Josef Gröne, Gröne, H J, Nelson, P. J., Felix Eichinger, Moll, Anton G., Kiss, Eva, Lindenmeyer, M T, Grone, E., Kiss, E, Nelson, P J, Gröne, Elisabeth, Anton G Moll, Schmid, H., Grone, H. J., Matthias Kretzler, Lindenmeyer, Maja T., Cohen, C D, Alexander Hahn, Moll, A G, Gröne, E, Holger Schmid, Hahn, A, Eichinger, F, Werner, T, Eichinger, F., Hahn, Alexander, Clemens D Cohen, Schmid, H, Martin Seifert, Kretzler, M., Werner, Thomas, Hahn, A., Seifert, M., Lindenmeyer, M. T., Kiss, E., Eichinger, Felix, Nelson, Peter J., Seifert, M, Kretzler, Matthias, Maja T Lindenmeyer, Cohen, Clemens D., Kretzler, M, Elisabeth Gröne, Gröne, Hermann-Josef, Peter J Nelson, Schmid, Holger, Eva Kiss, Cohen, C. D., Werner, T., Thomas Werner   +50 more
core   +1 more source

Plasmatic Profiling of Individuals With Combinations of Type 2 Diabetes Mellitus, Dyslipidemia and Periodontitis: A Cross‐Sectional Study

Oral Diseases, EarlyView.
ABSTRACT Aim The objective of this study was to investigate the global profile of plasmatic proteins of individuals affected simultaneously or not by type 2 diabetes mellitus (T2DM, well/poorly‐controlled), Dyslipidemia (DL), and Periodontitis (P). Methods Besides periodontal examination, plasma was collected for glycemic, and lipid analyses from 150 ...
François Isnaldo Dias Caldeira, Sâmia Cruz Tfaile Corbi, Alliny de Souza Bastos, Silvana Regina Perez Orrico, Cristiane Ribeiro Salmon, Yizhi Xiao, Walter Luiz Siqueira, Raquel Mantuaneli Scarel‐Caminaga   +7 more
wiley   +1 more source